Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL820145 | 0.72 | ALDH1A1 (0.35) | ALDH1A1KDM4EPOLBMAPTHTT | |
| Hydrochloric Acid SCHEMBL819271 | 0.70 | ALDH1A1 (0.34) | ALDH1A1KDM4EPOLBMAPTHTT | |
| Hydrochloric Acid SCHEMBL2796754 | 0.67 | ALDH1A1 (0.36) | ALDH1A1KDM4EPOLBMAPTHTT | |
| Hydrochloric Acid SCHEMBL2796752 | 0.67 | ALDH1A1 (0.36) | ALDH1A1KDM4EPOLBMAPTHTT | |
| SCHEMBL16834276 | 0.67 | MEN1 (0.39) | ALDH1A1KDM4EPOLBMAPTHTT | |
| SCHEMBL5395034 | 0.65 | ALDH1A1 (0.33) | ALDH1A1KDM4EPOLBMAPTHTT | |
| SCHEMBL4696412 | 0.65 | ALDH1A1 (0.33) | ALDH1A1KDM4EPOLBMAPTHTT | |
| SCHEMBL12867940 | 0.65 | ALDH1A1 (0.35) | ALDH1A1KDM4EPOLBMAPTHTT | |
| SCHEMBL2518941 | 0.64 | ALDH1A1 (0.31) | ALDH1A1KDM4EPOLBMAPTHTT | |
| SCHEMBL760838 | 0.64 | ALDH1A1 (0.33) | ALDH1A1KDM4EPOLBMAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023144521-A1 | USING HYPERPOLARISED 15N DERIVED SYNTHONS TO CREATE HYPERPHARMACEUTICALS THROUGH SABRE | UNIVERSITY OF YORK (GB) | 2023-08-03 | — | — | WO | disclosed |